Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.63 +0.04 (+1.54%)
At close: Sep 30, 2026 · 4:00 PM EDT

Rocket Pharmaceuticals (RCKT) Acquisitions (2018)

Updated

Rocket Pharmaceuticals (RCKT) recorded Acquisitions of $42.73 million in FY2022.

Analysis

Rocket Pharmaceuticals (RCKT) Acquisitions (2018) Analysis & Trends

  • Annual Acquisitions has a four-year compound annual growth rate of -13.5% (FY2018 to FY2022).
  • The FY2022 figure is the highest annual Acquisitions since FY2018.
  • Per Business Quant data, RCKT's Acquisitions was $76.35 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -17.24 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -23.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 11.21 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Rocket Pharmaceuticals 283.71 Mn 283.71 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 76.35 Mn
API Access

Rocket Pharmaceuticals Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=RCKT&period=max&api_key=YOUR_API_KEY